Treatment of left-sided ulcerative colitis with butyrate enemas: A controlled trial

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 5, 1996, Pages 729-736

  Steinhart, A H ^a,b   Hiruki, T ^c   Brzezinski, A ^d   Baker, J P ^a,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; ENEMA; PLACEBO; SHORT CHAIN FATTY ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON MUCOSA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENDOSCOPY; FEMALE; HUMAN; MALE; NUTRITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ULCERATIVE COLITIS;

EID: 0029797691     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.d01-509.x     Document Type: Article

References (28)

1. Cummings JH. Short chain fatty acids in the human colon. Gut 1981; 22: 763-79.
2. Fleming SE, Arce DS. Volatile fatty acids: Their production, absorption, utilization, and roles in human health. Clin Gastroenterol 1986; 15: 787-814.
3. Grimble G. Fibre, fermentation, flora, and flatus. Gut 1989; 30: 6-13.
4. McNeil NI, Cummings JH, James WPT. Short chain fatty acid absorption by the human large intestine. Gut 1978; 19: 819-22.
5. Ruppin H, Bar-Meir S, Soergel KH, Wood CM, Schmitt MGJ. Absorption of short-chain fatty acids by the colon. Gastroenterology 1980; 78: 1500-7.
6. Roediger WEW. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 1980; 21: 793-8.
7. Binder HJ, Mehta P. Characterization of butyrate-dependent electroneutral Na-Cl absorption in the rat distal colon. Pflugers A 1990; 417: 365-9.
8. Roediger WEW. The colonic epithelium in ulcerative colitis: An energy-deficiency disease. Lancet 1980; ii: 712-5.
9. Ellestad-Sayed JJ, Nelson RA, Adson MA, Palmer WM, Soule EH. Pantothenic acid, coenzyme A, and human chronic ulcerative and granulomatous colitis. Am J Clin Nutr 1976; 29: 1333-8.
10. Vernia P, Caprilli R, Latella G, et al. Fecal lactate and ulcerative colitis. Gastroenterology 1988; 95: 1564-8.
11. Roediger WEW, Heyworth M, Willoughby P, et al. Luminal ions and short chain fatty acids as markers of functional activity of the mucosa in ulcerative colitis. J Clin Pathol 1982; 35: 323-6.
12. Roediger WEW, Nance S. Selective reduction of fatty acid oxidation in colonocytes: Correlation with ulcerative colitis. Lipids 1990; 25: 646-52.
13. Harig JM, Soergel KH, Komorowski RA, Wood CM. Treatment of diversion colitis with short-chain-fatty acid irrigation. New Engl J Med 1989; 320: 23-8.
14. Breuer RI, Buto SK, Christ ML, et al. Rectal irrigation with short-chain fatty acids for distal ulcerative colitis. Dig Dis Sci 1991; 36: 185-7.
15. Scheppach W, Sommer H, Kirchner T, et al. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 1992; 103: 51-6.
16. Vernia P, Marcheggiano A, Caprilli R, et al. Short-chain fatty acid topical treatment in distal ulcerative colitis. Aliment Pharmacol Ther 1995; 9: 309-13.
17. Breuer RI, Christ ML, Lashner BA, et al. Short chain fatty acid rectal irrigation therapy for left-sided ulcerative colitis: a randomized, placebo-controlled clinical trial. Interim report. In: Binder HJ, Cummings JH, Soergel KH, eds. Short Chain Fatty Acids. Hingham: Kluwer and Associates, 1994: 214-20.
18. Steinhart AH, Brzezinski A, Baker JP. Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas. Am J Gastroenterol 1994; 89: 179-83.
19. Sutherland LR, Martin F, Greer S, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 1987; 92: 1894-8.
20. Riley SA, Mani V, Goodman MJ, et al. Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse. Gut 1988; 29: 669-74.
21. Watkinson G. Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate sodium. Br Med J 1958; 2: 1077-82.
22. Campieri M, Lanfranchi GA, Bazzocchi G, et al. Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas. Lancet 1981; ii: 270-1.
23. Campieri M, De Franchis R, Bianchi Porro G, Ranzi T, Brunetti G. Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. A randomized controlled trial. Scand J Gastroenterol 1990; 25: 663-8.
24. Ginsberg AL, Beck LS, McIntosh TM, Nochomovitz LE. Treatment of left-sided ulcerative colitis with 4-aminosalicylic acid enemas. A double-blind, placebo-controlled trial. Ann Intern Med 1988; 108: 195-9.
25. Senagore AJ, MacKeigan JM, Scheider M, Ebrom JS. Short-chain fatty acid enemas: a cost-effective alternative in the treatment of nonspecific proctosigmoiditis. Dis Colon Rectum 1992; 35: 923-7.
26. Roediger WE, Kapaniris O, Millard S. Lipogenesis from n-butyrate in colonocytes. Action of reducing agent and 5-aminosalicylic acid with relevance to ulcerative colitis. Mol Cell Biochem 1992; 118: 113-8.
27. Roediger WEW. The role of colonic mucosal metabolism in the pathogenesis of ulcerative colitis. In: Goebel H, Peskar BM, Malchow H, eds. Inflammatory Bowel Diseases - Basic Research and Clinical Implications. Lancaster, UK: MTP, 1988: 69-78.
28. Roediger WEW, Duncan A, Kapaniris O, Millard S. Reducing sulfur compounds of the colon impair colonocyte nutrition: Implications for ulcerative colitis. Gastroenterology 1993; 104: 802-9.